Ainos Inc Warrant 2022-29.07.27 on Ainos AIMDW 深 沪
等待开盘 09-17 09:30:00 美东时间
0.135
-0.015
-10.00%
华盛通- 最 高0.15
- 今 开0.12
- 成交量 710股
- 最 低 0.12
- 昨 收 0.15
- 总市值 0
- 52周最高 0.949
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.025
- 委 比 81.82%
- 总股本 --
- 历史最高 0.949
- 量 比 0.50
- 振 幅 20.00%
- 历史最低 0.025
- 每 手 1
- 风险率 0.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ainos Launches Patented AI Nose Platform For Industrial And Healthcare Markets, Unveils SmellTech-As-A-Service At Automation Taipei 2025
Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments UnderwaySmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead
08-14 21:39
Ainos, Inc Announces Its Investigational Low-Dose Oral Interferon-Alpha Drug Candidate, Veldona Has Received Formal Approval From Taiwan's Food And Drug Administration To Initiate A Clinical Study For Primary Sjögren's Syndrome
Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune DiseaseAinos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Texas incorporated, dual-platform AI and biotech
08-04 20:04
Ainos Regains Nasdaq Compliance, Accelerates AI Nose Platform Commercialization With 90-Day Execution Plan
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on
07-16 20:09
Ainos Announces 5-Yr Distribution Partnership With Solomon Technology To Fast-Track Ainos' AI Nose Platform Into Asia's Key Manufacturing Sectors
AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory AutomationPartnership Accelerates AI Scent Intelligence Deployment in Semiconductors, Robotics and MoreSAN DIEGO, CALIFORNIA /
07-07 20:07
Ainos To Implement Consolidation Of Its Common Stock, Effective June 30, 2025
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ("stock consolidation"), effective at the opening of trading on June 30, 2025.
06-26 23:02
Ainos Concludes Growth Financing From Lind Partners
Maintaining robust financial runway after the prepayment Reinforcing Ainos' com...
2024-08-06 19:30
Ainos, Inc. Announces 1-For-5 Stock Consolidation
Ainos, Inc. (NASDAQ:AIMD, AIMDW)))) ("Ainos," or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care testing, VELDONA® low-dose interferon therapeutics, and
2023-12-12 21:03
Ainos Announces Placement Of Initial $3M Tranche Of $10M Private Placement; Proceeds To Fund Company's Clinical Trials, Commercial Product Launch, And Working Capital; Initial Conversion Price Set At $1.50 Per Share
Proceeds to fund company's clinical trials, commercial product launch, and working capitalInitial conversion price set at $1.50 per shareSAN DIEGO, CA / ACCESSWIRE / September 25, 2023 / Ainos, Inc. (NASDAQ:AIMD,
2023-09-25 20:33
